Antagonistic, synergistic, and additive antibacterial interaction between ciprofloxacin and amoxicillin against Staphylococcus aureus

The aim of this in vitro study was to evaluate the interaction between ciprofloxacin and amoxicillin against beta‐lactamase‐producing Staphylococcus aureus. Concentration‐dependent curves for each individual drug were carried out to obtain the mean inhibitory concentration in the agar well diffusion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fundamental & clinical pharmacology 2023-02, Vol.37 (1), p.174-181
Hauptverfasser: Gómez‐Sánchez, Eduardo, Franco‐de la Torre, Lorenzo, Hernández‐Gómez, Adriana, Alonso‐Castro, Ángel Josabad, Serafín‐Higuera, Nicolás, Terán‐Rosales, Flavio, Bologna‐Molina, Ronell Eduardo, Isiordia‐Espinoza, Mario Alberto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of this in vitro study was to evaluate the interaction between ciprofloxacin and amoxicillin against beta‐lactamase‐producing Staphylococcus aureus. Concentration‐dependent curves for each individual drug were carried out to obtain the mean inhibitory concentration in the agar well diffusion assay. Then, different ratios of the ciprofloxacin–amoxicillin combination (0.5:0.5, 0.8:0.2, 0.2:0.8, 0.9:0.1, 0.1:0.9, 0.95:0.05, and 0.05:0.95) were assessed. Data were analyzed using the isobolographic analysis and interaction index. The isobolographic evaluation shows that the 0.9:0.1 and 0.95:0.05 ratios of the ciprofloxacin–amoxicillin combination produced a synergistic antimicrobial interaction, the 0.8:0.2, 0.2:0.8, 0.1:0.9, and 0.05:0.95 proportions showed an additive antibacterial effect, and the 0.5:0.5 proportion induced antagonistic antimicrobial effects. The interaction index showed similar outcomes to the isobolographic analysis. In conclusion, the data of this study mainly show antimicrobial additive results of the ciprofloxacin–amoxicillin combination against beta‐lactamase‐producing S. aureus.
ISSN:0767-3981
1472-8206
DOI:10.1111/fcp.12832